Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Alamar Biosciences r&d expenses
Research and development expenses are spending on new products and technology.
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.17M | +81.8% |
| Q2 FY2026 | Jun 30, 2026 | $13.82M | +66.4% |
| Q1 FY2026 | Mar 31, 2026 | $13.02M | – |
| Q3 FY2025 | Sep 30, 2025 | $10.21M | – |
| Q2 FY2025 | Jun 30, 2025 | $8.90M | – |
| Q1 FY2025 | Mar 31, 2025 | $8.30M | – |
See a number that looks wrong?